These findings suggest that Prx II regulated apoptosis of keratinocytes via the PI3K/AKT/GSK3β signaling pathway (Fig. 8), Prx II may therefore serve as a gene target for the development of therapeutic options that mediate apoptosis in order to treat psoriasis. This evidence concerns the gene AKT1 and psoriasis.